Logo image of CNK

CINEMARK HOLDINGS INC (CNK) Stock Fundamental Analysis

USA - NYSE:CNK - US17243V1026 - Common Stock

26.31 USD
-0.61 (-2.27%)
Last: 10/7/2025, 5:25:02 PM
26.31 USD
0 (0%)
After Hours: 10/7/2025, 5:25:02 PM
Fundamental Rating

5

Overall CNK gets a fundamental rating of 5 out of 10. We evaluated CNK against 80 industry peers in the Entertainment industry. CNK has an excellent profitability rating, but there are concerns on its financial health. CNK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CNK was profitable.
CNK had a positive operating cash flow in the past year.
In multiple years CNK reported negative net income over the last 5 years.
Of the past 5 years CNK 4 years had a positive operating cash flow.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

CNK has a better Return On Assets (5.88%) than 81.25% of its industry peers.
The Return On Equity of CNK (64.49%) is better than 97.50% of its industry peers.
CNK's Return On Invested Capital of 9.81% is amongst the best of the industry. CNK outperforms 86.25% of its industry peers.
CNK had an Average Return On Invested Capital over the past 3 years of 5.91%. This is below the industry average of 9.15%.
The 3 year average ROIC (5.91%) for CNK is below the current ROIC(9.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.88%
ROE 64.49%
ROIC 9.81%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

CNK has a Profit Margin of 8.98%. This is amongst the best in the industry. CNK outperforms 81.25% of its industry peers.
CNK's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 12.82%, CNK belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
CNK's Operating Margin has been stable in the last couple of years.
CNK has a Gross Margin of 64.08%. This is in the better half of the industry: CNK outperforms 72.50% of its industry peers.
CNK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.82%
PM (TTM) 8.98%
GM 64.08%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CNK is creating some value.
CNK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CNK has been increased compared to 5 years ago.
Compared to 1 year ago, CNK has an improved debt to assets ratio.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.28, we must say that CNK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.28, CNK is in line with its industry, outperforming 51.25% of the companies in the same industry.
CNK has a debt to FCF ratio of 8.05. This is a slightly negative value and a sign of low solvency as CNK would need 8.05 years to pay back of all of its debts.
CNK has a Debt to FCF ratio of 8.05. This is comparable to the rest of the industry: CNK outperforms 58.75% of its industry peers.
CNK has a Debt/Equity ratio of 4.40. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 4.40, CNK is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.4
Debt/FCF 8.05
Altman-Z 1.28
ROIC/WACC1.39
WACC7.08%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.91 indicates that CNK may have some problems paying its short term obligations.
The Current ratio of CNK (0.91) is comparable to the rest of the industry.
A Quick Ratio of 0.88 indicates that CNK may have some problems paying its short term obligations.
CNK has a Quick ratio (0.88) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.88
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.66% over the past year.
The Earnings Per Share has been growing slightly by 4.49% on average over the past years.
Looking at the last year, CNK shows a quite strong growth in Revenue. The Revenue has grown by 13.80% in the last year.
CNK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.47% yearly.
EPS 1Y (TTM)88.66%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%96.88%
Revenue 1Y (TTM)13.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%28.1%

3.2 Future

CNK is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.71% yearly.
Based on estimates for the next years, CNK will show a small growth in Revenue. The Revenue will grow by 5.28% on average per year.
EPS Next Y-27.37%
EPS Next 2Y3.19%
EPS Next 3Y7.71%
EPS Next 5YN/A
Revenue Next Year7.27%
Revenue Next 2Y7.48%
Revenue Next 3Y6.52%
Revenue Next 5Y5.28%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.38, CNK is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of CNK indicates a rather cheap valuation: CNK is cheaper than 86.25% of the companies listed in the same industry.
CNK's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.76.
A Price/Forward Earnings ratio of 12.17 indicates a correct valuation of CNK.
Based on the Price/Forward Earnings ratio, CNK is valued cheaper than 92.50% of the companies in the same industry.
CNK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.38
Fwd PE 12.17
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

83.75% of the companies in the same industry are more expensive than CNK, based on the Enterprise Value to EBITDA ratio.
CNK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CNK is cheaper than 92.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.93
EV/EBITDA 7.58
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The decent profitability rating of CNK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.2
EPS Next 2Y3.19%
EPS Next 3Y7.71%

3

5. Dividend

5.1 Amount

CNK has a Yearly Dividend Yield of 1.15%.
CNK's Dividend Yield is rather good when compared to the industry average which is at 21.41. CNK pays more dividend than 87.50% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, CNK's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.15%

5.2 History

CNK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNK Yearly Dividends per shareCNK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y3.19%
EPS Next 3Y7.71%
CNK Yearly Income VS Free CF VS DividendCNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CINEMARK HOLDINGS INC

NYSE:CNK (10/7/2025, 5:25:02 PM)

After market: 26.31 0 (0%)

26.31

-0.61 (-2.27%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-31 2025-10-31/bmo
Inst Owners123.23%
Inst Owner Change-0.01%
Ins Owners2.08%
Ins Owner Change-0.8%
Market Cap3.03B
Analysts77.65
Price Target34.17 (29.87%)
Short Float %11.41%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 1.15%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date08-27 2025-08-27 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.58%
Min EPS beat(2)-100.53%
Max EPS beat(2)-14.63%
EPS beat(4)1
Avg EPS beat(4)-4.7%
Min EPS beat(4)-100.53%
Max EPS beat(4)109.69%
EPS beat(8)4
Avg EPS beat(8)57.72%
EPS beat(12)6
Avg EPS beat(12)21.99%
EPS beat(16)7
Avg EPS beat(16)0.74%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)-0.41%
Revenue beat(4)2
Avg Revenue beat(4)0.86%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)3.21%
Revenue beat(8)6
Avg Revenue beat(8)1.89%
Revenue beat(12)9
Avg Revenue beat(12)2.59%
Revenue beat(16)12
Avg Revenue beat(16)2.59%
PT rev (1m)0%
PT rev (3m)0.68%
EPS NQ rev (1m)-0.53%
EPS NQ rev (3m)-22.07%
EPS NY rev (1m)-4.58%
EPS NY rev (3m)-15.61%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-7.37%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-2%
Valuation
Industry RankSector Rank
PE 14.38
Fwd PE 12.17
P/S 0.94
P/FCF 9.93
P/OCF 6.57
P/B 6.76
P/tB N/A
EV/EBITDA 7.58
EPS(TTM)1.83
EY6.96%
EPS(NY)2.16
Fwd EY8.22%
FCF(TTM)2.65
FCFY10.07%
OCF(TTM)4
OCFY15.22%
SpS27.97
BVpS3.89
TBVpS-9.54
PEG (NY)N/A
PEG (5Y)3.2
Profitability
Industry RankSector Rank
ROA 5.88%
ROE 64.49%
ROCE 11.34%
ROIC 9.81%
ROICexc 13.19%
ROICexgc 30.77%
OM 12.82%
PM (TTM) 8.98%
GM 64.08%
FCFM 9.47%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
ROICexc(3y)7.77%
ROICexc(5y)N/A
ROICexgc(3y)16.27%
ROICexgc(5y)N/A
ROCE(3y)6.83%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y17.77%
ROICexc growth 3YN/A
ROICexc growth 5Y8.59%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 4.4
Debt/FCF 8.05
Debt/EBITDA 3.23
Cap/Depr 79.01%
Cap/Sales 4.84%
Interest Coverage 2.98
Cash Conversion 75.53%
Profit Quality 105.54%
Current Ratio 0.91
Quick Ratio 0.88
Altman-Z 1.28
F-Score6
WACC7.08%
ROIC/WACC1.39
Cap/Depr(3y)64.73%
Cap/Depr(5y)52.5%
Cap/Sales(3y)4.78%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.66%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%96.88%
EPS Next Y-27.37%
EPS Next 2Y3.19%
EPS Next 3Y7.71%
EPS Next 5YN/A
Revenue 1Y (TTM)13.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%28.1%
Revenue Next Year7.27%
Revenue Next 2Y7.48%
Revenue Next 3Y6.52%
Revenue Next 5Y5.28%
EBIT growth 1Y52.76%
EBIT growth 3YN/A
EBIT growth 5Y-2.31%
EBIT Next Year74.37%
EBIT Next 3Y28.13%
EBIT Next 5Y16.59%
FCF growth 1Y40.92%
FCF growth 3Y64.6%
FCF growth 5Y4.05%
OCF growth 1Y35.07%
OCF growth 3Y41.01%
OCF growth 5Y-3.68%